Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.08 USD | +0.78% | -0.48% | -10.06% |
Apr. 11 | Harmony Biosciences, Bioprojet Enter Licensing Deal for Sleep Disorder Therapy | MT |
Apr. 03 | Harmony Biosciences Begins Phase 3 Trial of Pitolisant to Treat Prader-Willi Syndrome Symptoms | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.06% | 1.64B | |
+25.70% | 672B | |
+25.87% | 570B | |
-5.65% | 360B | |
+16.03% | 321B | |
+8.62% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-9.00% | 149B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Earnings Flash (HRMY) HARMONY BIOSCIENCES Posts Q4 EPS $0.79, vs. Street Est of $0.57